Clinical trial
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of…
NCT00468585 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00468585 |
|---|---|
| Title | Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model |
| Official title | A Multicenter, Phase I/II Study of Every Other Week Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Bevacizumab |
| Enrollment | 62 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | May 3, 2007 |
| Last update posted | Jan 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: